Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4

被引:12
|
作者
Perpina-Viciano, Cristina [1 ,2 ]
Isbilir, Ali [2 ,3 ]
Zarca, Aurelien [4 ]
Caspar, Birgit [5 ,6 ,7 ]
Kilpatrick, Laura E. [5 ,6 ,7 ]
Hill, Stephen J. [5 ,6 ,7 ]
Smit, Martine J. [4 ]
Lohse, Martin J. [2 ,3 ]
Hoffmann, Carsten [1 ,2 ]
机构
[1] Univ Jena, Univ Hosp Jena, Inst Mol Cell Biol, Ctr Mol Biomed CMB, Hans Knoll Str 2, D-07745 Jena, Germany
[2] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany
[3] Max Delbruck Ctr Mol Med, Berlin, Germany
[4] Vrije Univ, Amsterdam Inst Mol Med & Syst AIMMS, Div Med Chem, Amsterdam, Netherlands
[5] Univ Nottingham, Queens Med Ctr, Med Sch, Div Physiol Pharmacol & Neurosci,Sch Life Sci, Nottingham, England
[6] Univ Birmingham, Ctr Membrane Prot & Receptors Compare, The Midlands, England
[7] Univ Nottingham, The Midlands, England
基金
英国医学研究理事会; 欧盟地平线“2020”;
关键词
PROTEIN-COUPLED RECEPTOR; PARATHYROID-HORMONE RECEPTOR; CRYSTAL-STRUCTURE; RESIDENCE TIME; SMALL-MOLECULE; ACTIVATION; GPCR; MIGRATION; CANCER; LIGAND;
D O I
10.1124/mol.119.118448
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
G protein-coupled receptors (GPCRs) are biologic switches that transduce extracellular stimuli into intracellular responses in the cell. Temporally resolving GPCR transduction pathways is key to understanding how cell signaling occurs. Here, we investigate the kinetics and dynamics of the activation and early signaling steps of the CXC chemokine receptor (CXCR) 4 in response to its natural ligands CXC chemokine ligand (CXCL) 12 and macrophage migration inhibitory factor (MIF), using Forster resonance energy transfer-based approaches. We show that CXCR4 presents a multifaceted response to CXCL12, with receptor activation (approximate to 0.6 seconds) followed by a rearrangement in the receptor/G protein complex (approximate to 1 seconds), a slower dimer rearrangement (approximate to 1.7 seconds), and prolonged G protein activation (RA seconds). In comparison, MIF distinctly modulates every step of the transduction pathway, indicating distinct activation mechanisms and reflecting the different pharmacological properties of these two ligands. Our study also indicates that CXCR4 exhibits some degree of ligand-independent activity, a relevant feature for drug development. SIGNIFICANCE STATEMENT The CXC chemokine ligand (CXCL) 12/CXC chemokine receptor (CXCR) 4 axis represents a well-established therapeutic target for cancer treatment. We demonstrate that CXCR4 exhibits a multifaceted response that involves dynamic receptor dimer rearrangements and that is kinetically embedded between receptor-G protein complex rearrangements and G protein activation. The alternative endogenous ligand macrophage migration inhibitory factor behaves opposite to CXCL12 in each assay studied and does not lead to G protein activation. This detailed understanding of the receptor activation may aid in the development of more specific drugs against this target.
引用
收藏
页码:72 / 87
页数:16
相关论文
共 50 条
  • [1] Solubilization of the chemokine receptor CXCR4
    Staudinger, R
    Bandres, JC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (01) : 153 - 156
  • [2] CXCR4: chemokine receptor extraordinaire
    Murdoch, C
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 177 : 175 - 184
  • [3] Agonists for the Chemokine Receptor CXCR4
    Lefrancois, Marilou
    Lefebvre, Marie-Reine
    Saint-Onge, Genevieve
    Boulais, Philip E.
    Lamothe, Simon
    Leduc, Richard
    Lavigne, Pierre
    Heveker, Nikolaus
    Escher, Emanuel
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (08): : 597 - 602
  • [4] Expression and functional analysis of the chemokine receptor CXCR4 in human bladder cancer
    Tack, M
    Eisenhardt, A
    Rosskopf, D
    Lümmen, G
    Rübben, H
    Siffert, W
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 : R22 - R22
  • [5] Soluble chemokine receptor CXCR4 is present in human sera
    Malvoisin, Etienne
    Livrozet, Jean-Michel
    Makloufi, Djamila
    Vincent, Nadine
    [J]. ANALYTICAL BIOCHEMISTRY, 2011, 414 (02) : 202 - 207
  • [6] CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy
    Menichella, Daniela Maria
    Abdelhak, Belmadani
    Ren, Dongjun
    Shum, Andrew
    Frietag, Caroline
    Miller, Richard J.
    [J]. MOLECULAR PAIN, 2014, 10
  • [7] SYNTHETIC AGONISTS FOR THE CXCR4 CHEMOKINE RECEPTOR
    Lefrancois, Marilou
    Lefebvre, Marie-Reine
    Saint-Onge, Genevieve
    Boulais, Philip
    Gravel, Stephanie
    Lamothe, Simon
    Leduc, Richard
    Lavigne, Pierre
    Heveker, Nikolaus
    Eschert, Emanuel
    [J]. BIOPOLYMERS, 2011, 96 (04) : 472 - 472
  • [8] Chemokine receptor CXCR4 expression in endothelium
    Volin, MV
    Joseph, E
    Shockley, MS
    Davies, PF
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (01) : 46 - 53
  • [9] The dynamics of chemokine receptor CXCR4 endocytosis
    Rosselli-Murai, L. K.
    DeNies, M.
    White, M.
    Liu, A. P.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [10] Eosinophils Through the CXCR4 Chemokine Receptor
    Straub, Christof
    Pazdrak, Konrad
    Kurosky, Alexander
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB123 - AB123